Curriculum Vitae
Total Page:16
File Type:pdf, Size:1020Kb
CURRICULUM VITAE NAME: Pablo José Sánchez, M.D. BUSINESS ADDRESS: Department of Pediatrics Center for Perinatal Research Divisions of Neonatal-Perinatal Medicine and Pediatric Infectious Diseases The Ohio State University - Nationwide Children's Hospital The Research Institute at Nationwide Children's Hospital 700 Children's Drive, RB3, WB5245 Columbus, Ohio 43205-2664 614-355-6638; 614-355-5724 (phone) 614.355.5899 (fax) [email protected] CITIZENSHIP: USA EDUCATION: 1973 – 1977 Seton Hall University South Orange, New Jersey B.S., Biology (Cum Laude) 1977 – 1981 University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania Doctor of Medicine POSTGRADUATE TRAINING: 1981 – 1984 Pediatric Internship and Residency Children’s Hospital of Pittsburgh Pittsburgh, Pennsylvania 1984 – 1986 Neonatology Fellowship Babies Hospital Columbia-Presbyterian Medical Center New York, New York 1986 – 1988 Pediatric Infectious Diseases Fellowship University of Texas Southwestern Medical Center at Dallas Dallas, Texas POSITIONS HELD: 1988 – 1995 Assistant Professor of Pediatrics 1995 – 2001 Associate Professor of Pediatrics 2001 – 2013 Professor of Pediatrics (with tenure) Division of Neonatal-Perinatal Medicine Division of Pediatric Infectious Diseases University of Texas Southwestern Medical Center at Dallas 1 Dallas, Texas 2013 - Present Professor of Pediatrics (with tenure) Division of Neonatal-Perinatal Medicine Division of Pediatric Infectious Diseases The Ohio State University - Nationwide Children’s Hospital, Columbus, OH HOSPITAL AFFILIATIONS: 1998 – 2013 Parkland Health & Hospital System 5201 Harry Hines Blvd. Dallas, TX 75235 1998 – 2013 Children’s Medical Center of Dallas 1935 Medical District Drive Dallas, TX 75235 2013 – Present Nationwide Children’s Hospital 700 Children’s Drive Columbus, OH 43205 2014 – Present Wexner Medical Center at Ohio State University 410 W 10th Ave Columbus, OH 43210 COMMITTEES: 1988 – 2013 Member, Infection Control Committee Parkland Health and Hospital System 1995 – 2013 Committee of Infectious Diseases and Immunizations, Texas Pediatric Society, (Chair, 2004- 2009; Emeritus Chair, 2010-2011) 1997 – Present Member, Collaborative Antiviral Study Group, University of Alabama at Birmingham (NIAID) 1998 – 2000 UTSWMC representative, Texas Neonatal Clinical Research Study Group 2004 – 2013 Parkland Health & Hospital System Credentials Committee; Privileges Sub-Committee (Pediatric/Neonatology representative) 2004 – 2007 March of Dimes Parkland NICU Family Support Project Advisory Board 2 2006 – 2013 Institutional Review Board (#3), Alternate Member (UTSW) 2006 – 2013 Member, PMH Immunization Committee 2007 – 2013 Pharmacy & Therapeutics Committee, Children’s Medical Center Dallas (Neonatology, Pediatric Infectious Diseases representative) 2007 – 2010 Vaccines and Related Biological Products Advisory Committee, Food and Drug Administration (FDA) 2009 – 2015 Member, NICHD Pediatrics (CHHD-A) Subcommittee Grant Review Panel 2010 - 2012 FDA Pediatric Advisory Committee Meeting (Pediatric vaccines) 2011 – 2013 Member, Antimicrobial Stewardship Committee, Children’s Medical Center Dallas 2012 – 2015 Pediatric Academic Societies Meeting: Program Committee (PIDS; 2013-2015) 2014 – Present The Ohio State University College of Medicine Admissions Committee CERTIFICATION: American Board of Pediatrics: 11/16/86 Board of Perinatal-Neonatal Medicine: 11/3/89; re-certification: 1996, 4/30/2002, 12/31/2010 - present. Board of Pediatric Infectious Diseases: 11/15/94, re-certification: 5/28/2000, 10/2008, through present LICENSE: Pennsylvania New York Texas Ohio SOCIETY MEMBERSHIPS: American Academy of Pediatrics (Sections on Perinatal Medicine and Infectious Diseases; Texas, Ohio Chapters) Infectious Diseases Society of America (IDSA, Fellow) 3 Pediatric Infectious Diseases Society (Nominations and Awards Committee, elected post, 2005-2007; Council member, elected post, 2011-2015; Program committee, 2013-present) Society for Pediatric Research (Membership Secretary, elected post, 1999-04) Texas Pediatric Society (Committee on Infectious Diseases and Immunizations; Co-chair 2002-2003; Chair 2004-2009; through 2013) Southern Society for Pediatric Research (through 2013) Texas Infectious Diseases Society (through 2013) Society for Healthcare Epidemiology of America (SHEA; member, Pediatric Leadership Council) American Pediatric Society (1/2008-present) Infectious Diseases Society of Ohio (1/2015-present) European Society of Pediatric Infectious Diseases (ESPID; 2015-present) Central Ohio Pediatric Society (COPS; 2015-present) HONORS: Session Chair, Neonatal Infectious Diseases, Pediatric Academic Societies’ Meeting (SPR), 5/8/96; 5/14/05, 6/2009 Invited Participant, “Infection Control: A Focus on MRSA,” Consensus Panel, SmithKline Beecham, Virginia, 11/17 – 19/1995 Who’s Who in Medicine: 1995 – Present (#135076, Life member of National Register of Who’s Who, published 2002 edition) The Best Doctors in America: Central Region, 1996-1997 The Best Doctors in America: 1998 – Present Invited Participant, Centers for Disease Control and Prevention, Congenital Syphilis: 1998 STD Treatment Guidelines, 2/10–13/97; 2001 STD Treatment Guidelines, 9/26–28/2000; 2005 STD Treatment Guidelines, 4/19-21/05; 2010 STD Treatment Guidelines, 4/28-30/09; 2015 STD Treatment Guidelines, 5/2013 Invited Panelist, “The RSV-Asthma Link: The Emerging Story”, American Thoracic Society, Dallas, TX, 11/23/98 4 Collaborator (Syphilis), 2000, 2006, 2009, 2012 Red Book: Report of the Committee on Infectious Diseases, American Academy of Pediatrics Outstanding Scientific Contributions to Public Health, Nominee, 2001 STD Treatment Guidelines Team, CDC The Best Pediatricians in Dallas (Pediatric Infectious Diseases), D Magazine, 2002-2013 America’s Top Pediatricians, 2002 – 2007 Invited Expert Panelist, “Human anti-staphylococcal hyperimmunoglobulin for prevention of staphylococcal infections in preterm infants,” 9/10/2002 (INHIBITEX, Inc.) Invited Member, Editorial Advisory Board, Infectious Diseases in Children, 2003-present 2003 Golden Hands Award, given by PMH Infection Control Dept. for recognition of employee infection control awareness Ray Kroc Visiting Professor Fellowship, Massachusetts General Hospital, Boston, MA, 1/28- 1/31/2003 Invited Medical Faculty, InfaCare Infant Wellness Initiative, National Minority Health Month Foundation, Inc. 2003 Invited Speaker, The 4th Annual Dr. John J. Fangman Neonatology Lectureship, Children’s Hospitals and Clinics, Minneapolis, MN, 10/18-19/2004 Invited Speaker, Symposium on “The Return of Syphilis,” 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 11/2/04 Invited Guest, WHO Department of Reproductive Health and Research Controlling Sexually Transmitted and Reproductive Tract Infections, “Technical Consultation on the Elimination of Congenital Syphilis,” Geneva, Switzerland, 12/1-2/04 Invited Member, Numax Advisory Committee (MI-CP110), MedImmune, Inc., 2005. Invited External Consultant, Center for Disease Control and Prevention, U.S. Syphilis Elimination Effort (SEE), Atlanta, GA, 8/1-2/2005 Invited Speaker, 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 9/27/2006 (“The State of Antifungal Prophylaxis in Young Infants”) 5 Invited Speaker, Children’s Medical Research Institute Aliya Hefner Endowed Research Program, University of Oklahoma Health Sciences Center, Children’s Hospital of Oklahoma, Oklahoma City, OK, 8/30/2007 (“Congenital CMV: What’s New?”) Invited Expert Consultant, “Expert Consultation on Community-Based Approaches for Neonatal Sepsis Management,” London, England (Save the Children/Saving Newborn Lives, US Agency for International Development, WHO, Boston Univ. Center for International Health And Development, Johns Hopkins Univ. School of Public Health, Univ. of London, Centre for International Health and Development), 9/26-28/2007 Invited Participant, University of Alabama at Birmingham Collaborative Antiviral Study Group Leadership Retreat, Bethesda, MD, 12/3-4, 2007 Invited Representative, Society for Healthcare Epidemiology of America (SHEA), CDC-GBS Guidelines Meeting, CDC, Atlanta, GA, 6/22/23/09 Society for Pediatric Research, nominating committee, 2009 Dallas Area Breastfeeding Alliance, Recognition Award for Outstanding Support of Breastfeeding, 8/2009 Invited Speaker, University of Minnesota, Minneapolis, MN, 4th Annual Jamie McNew Endowed Fellowship Lectureship, Grand Rounds, 2/10/10 (“Perinatal Infections: Overview and Update”) Pfizer Visiting Professor, Albany Medical Center, Albany, NY 9/29-10/1/2010 Invitee, Future Directions Meeting (STD), Centers for Disease Control and Prevention, Atlanta, GA, 9/21/11 Invited Usher Lecture, “Congenital CMV Infection: What Now?” Pediatric Grand Rounds, McGill University, Montreal, Canada, 10/23/12. Consultant, Global Experts Meeting (GEM), AbbVie, 2012-2014 Invited Participant (Society for Healthcare Epidemiology of America representative), Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC, 2010 Top Doctors (Pediatric Infectious Diseases), Columbus Monthly, 2014 – 2016 Nationwide Children’s Hospital Neonatology Fellows: 2015 Distinguished Faculty Award Invited Participant, Syphilis Summit meeting, CDC, Atlanta, GA, 1/26-28/16 "Best of the Best", The American Registry, 2016 6 NIH, Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section (IRAP), San Francisco, CA, 6/9-10/16